Back to Search

IMRAN KHALIL, M.D

M.D

Interventional Cardiology Physician

NPI: 1912282948IndividualAccepts Medicare

Specialties, Licenses & Credentials

Student in an Organized Health Care Education/Training Program

Student in an Organized Health Care Education/Training Program

Code: 390200000X

Interventional Cardiology PhysicianPrimary

Internal Medicine — Interventional Cardiology

Code: 207RI0011X

MD.43540(AL)298324(NY)
Hospitalist Physician

Hospitalist

Code: 208M00000X

52814(CT)

CMS Specialties

PrimaryINTERVENTIONAL CARDIOLOGY

Education

OTHER

Class of 2009

Research & Publications (20)

Octaarginine-modified liposomes: enhanced cellular uptake and controlled intracellular trafficking.
PMID 18242018·Int J Pharm·2008
6-review
Octaarginine-modified multifunctional envelope-type nanoparticles for gene delivery.
PMID 17268535·Gene Ther·2007
4-observational
Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery.
PMID 16507881·Pharmacol Rev·2006
6-review
Aneurysmal bone cyst of the cervical spine in a child: case report and review of the surgical role.
PMID 16488257·Surg Neurol·2006
5-case
High density of octaarginine stimulates macropinocytosis leading to efficient intracellular trafficking for gene expression.
PMID 16326716·J Biol Chem·2006
7-preclinical
The roles of the pfcrt 76T and pfmdr1 86Y mutations, immunity and the initial level of parasitaemia, in predicting the outcome of chloroquine treatment in two areas with different transmission intensities.
PMID 16004703·Ann Trop Med Parasitol·2005
7-preclinical
Response of Plasmodium falciparum to cotrimoxazole therapy: relationship with plasma drug concentrations and dihydrofolate reductase and dihydropteroate synthase genotypes.
PMID 16014854·Am J Trop Med Hyg·2005
3-trial
Mechanism of improved gene transfer by the N-terminal stearylation of octaarginine: enhanced cellular association by hydrophobic core formation.
PMID 14973542·Gene Ther·2004
7-preclinical
Dihydrofolate reductase and dihydropteroate synthase genotypes associated with in vitro resistance of Plasmodium falciparum to pyrimethamine, trimethoprim, sulfadoxine, and sulfamethoxazole.
PMID 12812351·Am J Trop Med Hyg·2003
7-preclinical
Pyrimethamine/sulfadoxine combination in the treatment of uncomplicated falciparum malaria: relation between dihydropteroate synthase/dihydrofolate reductase genotypes, sulfadoxine plasma levels, and treatment outcome.
PMID 12408659·Am J Trop Med Hyg·2002
7-preclinical

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Via practice · 2 locations total

Address
4300 W MAIN ST STE 21
DOTHAN, AL 36305

Locations (2)

Practice Location

4300 W MAIN ST STE 21, DOTHAN, AL
(334) 699-7900

Practice Location

1481 W 10th St, Indianapolis, IN
(317) 988-4403

Quick Facts

NPI
1912282948
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
4
Locations
2
Years in Practice
17
Publications
20

Are you this provider?

Claim Your Profile